BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37263448)

  • 1. Role of bacterial efflux pump proteins in antibiotic resistance across microbial species.
    Kumawat M; Nabi B; Daswani M; Viquar I; Pal N; Sharma P; Tiwari S; Sarma DK; Shubham S; Kumar M
    Microb Pathog; 2023 Aug; 181():106182. PubMed ID: 37263448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.
    Li XZ; Plésiat P; Nikaido H
    Clin Microbiol Rev; 2015 Apr; 28(2):337-418. PubMed ID: 25788514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extending the Potency and Lifespan of Antibiotics: Inhibitors of Gram-Negative Bacterial Efflux Pumps.
    Duffey M; Jumde RP; da Costa RMA; Ropponen HK; Blasco B; Piddock LJV
    ACS Infect Dis; 2024 May; 10(5):1458-1482. PubMed ID: 38661541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial antibiotic efflux systems of medical importance.
    Köhler T; Pechère JC; Plésiat P
    Cell Mol Life Sci; 1999 Nov; 56(9-10):771-8. PubMed ID: 11212337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria.
    Piddock LJ
    Clin Microbiol Rev; 2006 Apr; 19(2):382-402. PubMed ID: 16614254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of bacterial multidrug efflux pumps during infection.
    Laborda P; Molin S; Johansen HK; Martínez JL; Hernando-Amado S
    World J Microbiol Biotechnol; 2024 Jun; 40(7):226. PubMed ID: 38822187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Evolutionary Conservation of Escherichia coli Drug Efflux Pumps Supports Physiological Functions.
    Teelucksingh T; Thompson LK; Cox G
    J Bacteriol; 2020 Oct; 202(22):. PubMed ID: 32839176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efflux-mediated Multidrug Resistance in Critical Gram-negative Bacteria and Natural Efflux Pump Inhibitors.
    Nanjan P; Bose V
    Curr Drug Res Rev; 2024 Jan; ():. PubMed ID: 38288795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RND Efflux Pump Induction: A Crucial Network Unveiling Adaptive Antibiotic Resistance Mechanisms of Gram-Negative Bacteria.
    Novelli M; Bolla JM
    Antibiotics (Basel); 2024 May; 13(6):. PubMed ID: 38927168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plant-based Natural Products as inhibitors for Efflux Pumps to Reverse Multidrug Resistance in
    Ramalingam S; Chandrasekar MJN; Krishnan GGN; Nanjan MJ
    Mini Rev Med Chem; 2024; 24(3):272-288. PubMed ID: 37038687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permeability barriers of Gram-negative pathogens.
    Zgurskaya HI; Rybenkov VV
    Ann N Y Acad Sci; 2020 Jan; 1459(1):5-18. PubMed ID: 31165502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial efflux pumps excrete SYTO™ dyes and lead to false-negative staining results.
    Minero GAS; Larsen PB; Hoppe ME; Meyer RL
    Analyst; 2024 Apr; 149(8):2232-2235. PubMed ID: 38445898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary supramolecular drug associates in perfecting the multidrug therapy against multidrug resistant bacteria.
    Sahoo P
    Front Immunol; 2024; 15():1352483. PubMed ID: 38415251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BacEffluxPred: A two-tier system to predict and categorize bacterial efflux mediated antibiotic resistance proteins.
    Pandey D; Kumari B; Singhal N; Kumar M
    Sci Rep; 2020 Jun; 10(1):9287. PubMed ID: 32518231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonlethal Molecular Nanomachines Potentiate Antibiotic Activity Against Gram-Negative Bacteria by Increasing Cell Permeability and Attenuating Efflux.
    Santos AL; Liu D; van Venrooy A; Beckham JL; Oliver A; Tegos GP; Tour JM
    ACS Nano; 2024 Jan; 18(4):3023-3042. PubMed ID: 38241477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efflux pumps as potential targets for biofilm inhibition.
    Ren J; Wang M; Zhou W; Liu Z
    Front Microbiol; 2024; 15():1315238. PubMed ID: 38596384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput computational screening for identification of potential hits against bacterial Acriflavine resistance protein B (AcrB) efflux pump.
    Rathod S; Dey S; Choudhari P; Mahuli D; Rochlani S; Dhavale R; Chaudhari S; Tamboli Y; Kilbile J; Rajakumara E
    J Biomol Struct Dyn; 2024 Jan; ():1-17. PubMed ID: 38264919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of escape from the antibacterial activity of metal-based nanoparticles in clinically relevant bacteria: A systematic review.
    Salas-Orozco MF; Lorenzo-Leal AC; de Alba Montero I; Marín NP; Santana MAC; Bach H
    Nanomedicine; 2024 Jan; 55():102715. PubMed ID: 37907198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combating Drug-Resistant Bacteria Using Photothermally Active Nanomaterials: A Perspective Review.
    Kaur K; Reddy S; Barathe P; Shriram V; Anand U; Proćków J; Kumar V
    Front Microbiol; 2021; 12():747019. PubMed ID: 34867863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentafluorosulfanyl-substituted biaryl derivatives as MATE-type transporter inhibitors targeting drug-resistant bacteria.
    Shinya S; Kawai K; Kobayashi N; Karuo Y; Tarui A; Sato K; Otsuka M; Omote M
    Bioorg Med Chem; 2024 Feb; 99():117606. PubMed ID: 38262304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.